248.619.01013 Molecular NeuroImaging — New Haven, Connecticut

248.619.01013 Molecular NeuroImaging is a clinical research site located in New Haven, Connecticut, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

248.619.01013 Molecular NeuroImaging has participated in 1 clinical trials.

Therapeutic areas: Parkinson Disease.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 248.619.01013 Molecular NeuroImaging?

248.619.01013 Molecular NeuroImaging has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 248.619.01013 Molecular NeuroImaging conducted?

248.619.01013 Molecular NeuroImaging has 1 clinical trials on record. Their work covers Parkinson Disease.

Is 248.619.01013 Molecular NeuroImaging accredited by Crixeo Health?

248.619.01013 Molecular NeuroImaging has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 248.619.01013 Molecular NeuroImaging?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.